[HTML][HTML] Optical coherence tomography angiography measurements in multiple sclerosis: a systematic review and meta-analysis

S Mohammadi, M Gouravani, MA Salehi… - Journal of …, 2023 - Springer
Background and objectives Recent literature on multiple sclerosis (MS) demonstrates the
growing implementation of optical coherence tomography–angiography (OCT-A) to discover …

[HTML][HTML] Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): current understanding and challenges

A Al-Ani, JJ Chen, F Costello - Journal of Neurology, 2023 - Springer
New diagnostic criteria for myelin oligodendrocyte glycoprotein antibody-associated disease
(MOGAD) have recently been proposed, distinguishing this syndrome from other …

[HTML][HTML] The Acute Optic Neuritis Network (ACON): Study protocol of a non-interventional prospective multicenter study on diagnosis and treatment of acute optic …

S Asseyer, N Asgari, J Bennett, O Bialer… - Frontiers in …, 2023 - frontiersin.org
Optic neuritis (ON) often occurs at the presentation of multiple sclerosis (MS), neuromyelitis
optica spectrum disorders (NMOSD), and myelin oligodendrocyte glycoprotein (MOG) …

Time to steroids impacts visual outcome of optic neuritis in MOGAD

J Rode, J Pique, A Maarouf, X Ayrignac… - Journal of Neurology …, 2023 - jnnp.bmj.com
Background To characterise the response to treatment of inaugural optic neuritis (ON) in
patients with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) …

[HTML][HTML] The potential pathogenicity of myelin oligodendrocyte glycoprotein antibodies in the optic pathway

M Lerch, A Bauer, M Reindl - Journal of Neuro-Ophthalmology, 2023 - journals.lww.com
Background: Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease
(MOGAD) is an acquired inflammatory demyelinating disease with optic neuritis (ON) as the …

Brain and spinal cord atrophy in NMOSD and MOGAD: current evidence and future perspectives.

L Lorefice, R Cortese - Multiple Sclerosis and Related Disorders, 2024 - Elsevier
Neuromyelitis optica spectrum disorder (NMOSD) is a severe form of inflammation of the
central nervous system (CNS) including acute myelitis, optic neuritis and brain syndrome …

Subclinical damage to the contralateral eye in unilateral optic neuritis: A longitudinal study.

Y Zhang, Y Qiu, L Chen, T Guo, X Xu, X Liu, Y Fu… - Multiple Sclerosis and …, 2023 - Elsevier
Background Early detection of subclinical injuries can lead to a correct diagnosis and help
control the advancement of the condition. This study aims to investigate the presence of …

The influence of MOGAD on diagnosis of multiple sclerosis using MRI

R Geraldes, G Arrambide, B Banwell, À Rovira… - Nature Reviews …, 2024 - nature.com
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is an
immune-mediated demyelinating disease that is challenging to differentiate from multiple …

Trans-Synaptic Degeneration in the Visual Pathway in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease

L Bollo, G Arrambide, A Cobo-Calvo, JV Alvarez… - Neurology, 2024 - AAN Enterprises
Background and Objectives We aimed to assess the presence of retinal neurodegeneration
independent of optic neuritis (ON) in myelin oligodendrocyte glycoprotein antibody …

NMOSD and MOGAD: an evolving disease spectrum

A Uzawa, FC Oertel, M Mori, F Paul… - Nature Reviews …, 2024 - nature.com
Neuromyelitis optica (NMO) spectrum disorder (NMOSD) is a relapsing inflammatory
disease of the CNS, characterized by the presence of serum aquaporin 4 (AQP4) …